Expert Consensus | Clinical Applications and Recommendations for ePRO in Oncology Nutrition

Today we are sharing an expert consensus published in the first half of the year
—"Expert Consensus on the Clinical Application of Patient-Reported Outcome-Based Oncology Nutrition Therapy Systems" (2024 Edition)—which notes that electronic patient-reported outcome (ePRO) systems can be applied to nutrition screening, monitoring, and management to improve intervention efficiency, reduce the burden on healthcare staff, and encourage patient engagement in nutrition interventions. By leveraging the convenience of the system, out-of-hospital management models can be further optimized, thereby promoting efficient, full-course nutrition diagnosis, treatment, and management for oncology patients. Below is a summary of the key questions and recommendations presented in the Expert Consensus:
|
Question
/Recommendation
|
Evidence
Grade
|
Recommendation
Strength
|
|
Related to full-course cancer rehabilitation management
|
||
|
Question
1: Can patient-reported outcomes combined with AI technology play a role in full-course cancer rehabilitation management?
|
||
|
Recommendation
1: The integration of PRO and AI technology can optimize medical prediction models and improve the quality of shared decision-making between clinicians and patients; research and application in full-course rehabilitation management for cancer patients are recommended.
|
Level III
|
Strong recommendation
|
|
Recommendation
2: The application of PRO combined with AI models in clinical nutrition management terminals is recommended to provide patients outside the hospital with real-time answers to questions and individualized nutrition education, thereby improving their nutritional status and quality of life.
|
Level III
|
Weak recommendation
|
|
Related to oncology nutrition therapy systems
|
|
|
|
Question
1: Can electronic patient-reported outcome (ePRO) systems be used for nutritional screening?
|
||
|
Recommendation
1: Using an ePRO system to conduct digital nutritional screening for oncology patients is recommended to achieve early identification and dynamic rescreening of malnutrition, reducing the workload of healthcare personnel while improving the efficiency and effectiveness of nutritional interventions.
|
Level II
|
Strong recommendation
|
|
Recommendation
2: The development of ePRO systems should consider the needs of older adults, providing modes that are easy to read and enter text in to optimize ease of use.
|
Level III
|
Strong recommendation
|
|
Recommendation
3: ePRO systems should incorporate nutrition screening scales that are simple and easy to understand, can be completed independently by patients, and have been validated for reliability and validity.
|
Level I
|
Strong recommendation
|
|
Question
2: Can electronic patient-reported outcome systems be used for the management of cancer nutrition-related symptoms?
|
||
|
Recommendation
4: Use of ePRO systems is recommended for symptom monitoring and management in patients with cancer to improve symptom status, nutritional status, treatment adherence, physical function, and quality of life, and to prolong patient survival.
|
Level I
|
Strong recommendation
|
|
Recommendation
5: It is recommended that symptom alert functionality be built into the ePRO system, and that an alert response mechanism for the healthcare team be established in advance based on actual clinical circumstances, with respective responsibilities clarified and integrated into routine workflows to ensure the timeliness and effectiveness of symptom intervention.
|
Level II
|
Strong recommendation
|
|
Recommendation
6: It is recommended to use the ePRO system for continuous patient monitoring during treatment intervals and after antitumor therapy to maximize clinical benefit for patients.
|
Level II
|
Strong recommendation
|
|
Question
3: Can an electronic patient-reported outcome (ePRO) system be used to monitor nutritional indicators?
|
||
|
Recommendation
7: It is recommended to use an ePRO system to continuously monitor anthropometric data and body composition indicators, and to provide patients with timely and effective interventions based on trends in the monitored indicators to improve their nutritional status and related clinical outcomes.
|
Level II
|
Strong recommendation
|
|
Recommendation
8: It is recommended that the ePRO system be configured with features such as data validation and instructional support to improve the accuracy and completeness of patient-reported data.
|
Level II
|
Weak recommendation
|
|
Recommendation
9: It is recommended to appropriately set the number of monitoring indicators in the ePRO system to reduce patient burden and ensure continued patient participation.
|
Level II
|
Weak recommendation
|
|
Question
4: Can patient-reported outcome measures be used in oncology nutrition clinical studies?
|
||
|
Recommendation
10: It is recommended to include PROMs in oncology nutrition clinical studies to evaluate the effectiveness of nutrition therapy and clinical benefit to patients.
|
Level II
|
Weak recommendation
|
|
Recommendation
11: It is recommended to use PROMs validated as reliable and valid in oncology populations.
|
Level I
|
Strong recommendation
|
|
Recommendation
12: Compared with traditional dietary assessment, dietary self-assessment tools for oncology patients have good accuracy and acceptability and can reduce the labor and time costs of dietary assessment in clinical studies; they are recommended for use as PROMs in oncology nutrition clinical studies.
|
Level II
|
Weak recommendation
|
EClinCloud: Integrated eCOA Services
EClinCloud
eCOA system has continuously refined the functionality of its controls to accommodate the varying structures of scales to the greatest extent possible, and now offers the most comprehensive functional modules, logic configurations, condition presets, and more, enabling broader data capture applications. The system also integrates AI technology to enable intelligent information collection and data analysis, significantly improving study efficiency and quality.
In addition to scale digitization (eCOA), EClinCloud provides professional integrated services—including scale due diligence, license acquisition, translation validation, and rater training—to provide support throughout the full clinical trial lifecycle centered on the study protocol.
EClinCloud has extensive experience in oncology treatment and looks forward to collaborating with you!

